RK

Rama Krishna Reddy Isanaka

Active Director Designated Partner DIN 01663020
DIN 01663020 First appointment May 1996 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 10 historical roles
Total affiliations 13 Since May 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Rama Krishna Reddy Isanaka

Data last updated:

Rama Krishna Reddy Isanaka is a Designated Partner at Issar Pharmaceuticals Llp (since 2023), Partner at Magnitia It Solutions Llp (since 2021) and Designated Partner at Relief Art Gallery Llp (since 2018). The companies operate in Paper, Education and Business Services. Earlier, Rama Krishna Reddy Isanaka was a Director at Indian Institute Of Cancer And Research Private Limited (2007–2008) and Director at Rk Asquare Private Limited (1999–2012) and 8 more.

DIN 01663020
Primary Designation Designated Partner
Industry Paper
First Appointment 08 May 1996
Oldest Company Age 30 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Apr 20232023Active
Partner25 Dec 20212019Active
Designated Partner24 May 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 May 20072007Active
Rk Asquare Private Limited U72100TG1999PTC031954
Director22 Jun 19991999Active
Continental Wool Limited U17117TG1996PLC024019
Director08 May 19961996Active
Director07 Mar 20072007₹21.4 Lakh (FY 2024)Active
Ithc Solutions Private Limited U74999TG2019PTC136697
Director08 Nov 20192019Strike Off
Issar Cs Bio Private Limited U24100TG2013PTC085834
Director19 Feb 20132013Strike Off
Issar Remedies Private Limited U24230TG2020PTC142029
Managing Director22 Jul 20202020Strike Off
Director02 Sep 19991995₹8.31 Cr (FY 2024)Converted To Llp
Director21 Jun 20112011₹49.2 Lakh (FY 2023)Under Liquidation
Director16 Oct 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rama Krishna Reddy Isanaka

Directorship timeline

Open interactive timeline →
Issar Pharmaceuticals Llp
Relief Art Gallery Llp
Ithc Solutions Private Limited
Issar Cs Bio Private Limited
Premium access

Shareholding and investment profile for Rama Krishna Reddy Isanaka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Krishna Reddy Isanaka

Rama Krishna Reddy Isanaka currently holds 3 directorships: Issar Pharmaceuticals Llp (Designated Partner, since 07 Apr 2023); Magnitia It Solutions Llp (Partner, since 25 Dec 2021); Relief Art Gallery Llp (Designated Partner, since 24 May 2018).

Rama Krishna Reddy Isanaka was first appointed on 08 May 1996 as Director at Continental Wool Limited. The most recent appointment on record is 07 Apr 2023 at Issar Pharmaceuticals Llp.

Rama Krishna Reddy Isanaka held 10 earlier board appointments: Indian Institute Of Cancer And Research Private Limited (Director, 11 May 2007 to 31 Dec 2008); Rk Asquare Private Limited (Director, 22 Jun 1999 to 16 Feb 2012); Continental Wool Limited (Director, 08 May 1996 to 01 Oct 2012); Square Feet Constructions Private Limited (Director, 07 Mar 2007 to 08 Sep 2020); Ithc Solutions Private Limited (Director, from 08 Nov 2019); and 5 more.

The current boards of Rama Krishna Reddy Isanaka's companies include Isanaka Shaalini (Issar Pharmaceuticals Llp), Gottigundala Ananthreddy (Magnitia It Solutions Llp), Mumma Reddy Gopal Reddy (Magnitia It Solutions Llp), Masooma Khaleel (Relief Art Gallery Llp), Mohmmad Rafi Uddin Khaleel (Relief Art Gallery Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available